Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,524.40
-48.00 (-3.05%)
May 29, 2026, 3:29 PM IST
Ipca Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 11,411 | 7,377 | 5,474 | 4,713 | 8,841 |
Depreciation & Amortization | 4,181 | 3,913 | 3,494 | 2,539 | 2,257 |
Other Amortization | - | 64.8 | 78.4 | 76.3 | 67.4 |
Loss (Gain) From Sale of Assets | -3,406 | -27.6 | -38.5 | -160.5 | 0.3 |
Asset Writedown & Restructuring Costs | 115.7 | 1,168 | 9.3 | 28.4 | 113.6 |
Loss (Gain) From Sale of Investments | 289.4 | 1,504 | -614.5 | 13.8 | -27.8 |
Stock-Based Compensation | 8.1 | 20.6 | 30.6 | - | - |
Provision & Write-off of Bad Debts | 79.9 | 38 | 8.3 | 22.7 | 11.6 |
Other Operating Activities | 1,680 | 919 | 1,921 | 335 | 25.2 |
Change in Accounts Receivable | -489.1 | -2,177 | -758 | -681 | -802.4 |
Change in Inventory | -1,706 | -915.6 | -947 | 1,146 | -2,492 |
Change in Accounts Payable | 667.7 | 726.6 | 214.9 | -324 | -1,097 |
Change in Other Net Operating Assets | -1,412 | 601.1 | 574.2 | 348.9 | 1,664 |
Operating Cash Flow | 11,420 | 13,213 | 9,447 | 8,058 | 8,561 |
Operating Cash Flow Growth | -13.57% | 39.87% | 17.23% | -5.87% | -21.47% |
Capital Expenditures | -6,560 | -7,756 | -4,113 | -4,945 | -4,790 |
Sale of Property, Plant & Equipment | 3,390 | 53.3 | 86.2 | 361.5 | 28.4 |
Cash Acquisitions | - | - | -15,429 | -105.9 | -301.1 |
Investment in Securities | 35.3 | -334.5 | 396.7 | -453.4 | -3,917 |
Other Investing Activities | 735.4 | -658.1 | 6,121 | -2,177 | 429.1 |
Investing Cash Flow | -2,468 | -8,695 | -12,918 | -7,250 | -8,551 |
Short-Term Debt Issued | - | - | - | 2,943 | 1,933 |
Long-Term Debt Issued | - | 2,184 | 1,237 | 3,917 | 4,137 |
Total Debt Issued | - | 2,184 | 1,237 | 6,860 | 6,070 |
Short-Term Debt Repaid | -777.6 | -639.4 | -3,038 | - | - |
Long-Term Debt Repaid | -5,418 | -2,616 | -1,874 | -357.6 | -726 |
Total Debt Repaid | -6,195 | -3,255 | -4,913 | -357.6 | -726 |
Net Debt Issued (Repaid) | -6,195 | -1,072 | -3,676 | 6,502 | 5,344 |
Common Dividends Paid | -524.1 | -1,015 | -507.4 | -1,015 | -1,015 |
Other Financing Activities | -815.8 | -743.5 | -1,343 | -414.8 | -61.8 |
Financing Cash Flow | -7,535 | -2,830 | -5,526 | 5,072 | 4,268 |
Miscellaneous Cash Flow Adjustments | -0.1 | - | 765 | - | 41.2 |
Net Cash Flow | 1,417 | 1,688 | -8,232 | 5,881 | 4,319 |
Free Cash Flow | 4,860 | 5,458 | 5,334 | 3,113 | 3,771 |
Free Cash Flow Growth | -10.95% | 2.32% | 71.31% | -17.44% | -48.24% |
Free Cash Flow Margin | 4.95% | 6.10% | 6.92% | 4.98% | 6.47% |
Free Cash Flow Per Share | 19.16 | 21.51 | 21.02 | 12.27 | 14.87 |
Cash Interest Paid | - | 743.5 | 1,343 | 414.8 | 61.8 |
Cash Income Tax Paid | - | 3,613 | 2,963 | 2,237 | 2,020 |
Levered Free Cash Flow | 8,602 | -145.6 | -6,836 | 1,904 | 1,448 |
Unlevered Free Cash Flow | 9,077 | 381.4 | -5,978 | 2,186 | 1,493 |
Change in Working Capital | -2,940 | -1,765 | -915.9 | 489.9 | -2,727 |